|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
61,890,000 |
Market
Cap: |
N/A |
Last
Volume: |
2,615,875 |
Avg
Vol: |
1,187,095 |
52
Week Range: |
$7.07 - $7.07 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Related Products |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Barrett Ronald W |
Chief Executive Officer |
|
2011-08-11 |
4 |
B |
$6.59 |
$49,443 |
D/D |
7,500 |
48,851 |
2.81 |
- |
|
Angotti Vincent |
SVP & CCO |
|
2011-08-10 |
4 |
D |
$6.45 |
$5,915 |
D/D |
(917) |
16,210 |
|
- |
|
Angotti Vincent |
SVP & CCO |
|
2011-08-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,500 |
17,127 |
|
- |
|
Cundy Kenneth C |
SVP, Preclinical Development |
|
2011-07-18 |
4 |
OE |
$1.50 |
$4,500 |
D/D |
3,000 |
32,068 |
|
- |
|
Cundy Kenneth C |
SVP, Preclinical Development |
|
2011-03-14 |
4 |
D |
$7.20 |
$26,726 |
D/D |
(3,712) |
25,862 |
|
- |
|
Cundy Kenneth C |
SVP, Preclinical Development |
|
2011-03-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,000 |
29,574 |
|
- |
|
Savello David R |
SVP, Development |
|
2011-03-14 |
4 |
D |
$7.20 |
$26,878 |
D/D |
(3,733) |
35,975 |
|
- |
|
Savello David R |
SVP, Development |
|
2011-03-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,000 |
39,708 |
|
- |
|
Harris William G |
SVP, Finance and CFO |
|
2011-03-14 |
4 |
D |
$7.20 |
$26,863 |
D/D |
(3,731) |
44,039 |
|
- |
|
Harris William G |
SVP, Finance and CFO |
|
2011-03-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,000 |
47,770 |
|
- |
|
Bosko Gianna M |
SVP, CAO, GC and secretary |
|
2011-03-14 |
4 |
D |
$7.20 |
$23,105 |
D/D |
(3,209) |
16,959 |
|
- |
|
Bosko Gianna M |
SVP, CAO, GC and secretary |
|
2011-03-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,750 |
20,168 |
|
- |
|
Angotti Vincent |
SVP & CCO |
|
2011-03-14 |
4 |
D |
$7.20 |
$26,554 |
D/D |
(3,688) |
14,627 |
|
- |
|
Angotti Vincent |
SVP & CCO |
|
2011-03-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,000 |
18,315 |
|
- |
|
Harris William G |
SVP, Finance and CFO |
|
2011-01-31 |
4 |
D |
$7.88 |
$1,655 |
D/D |
(210) |
37,770 |
|
- |
|
Harris William G |
SVP, Finance and CFO |
|
2011-01-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
500 |
37,980 |
|
- |
|
Savello David R |
SVP, Development |
|
2011-01-31 |
4 |
D |
$7.88 |
$1,655 |
D/D |
(210) |
29,708 |
|
- |
|
Savello David R |
SVP, Development |
|
2011-01-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
500 |
29,918 |
|
- |
|
Cundy Kenneth C |
SVP, Preclinical Development |
|
2011-01-31 |
4 |
D |
$7.88 |
$2,072 |
D/D |
(263) |
19,574 |
|
- |
|
Cundy Kenneth C |
SVP, Preclinical Development |
|
2011-01-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
625 |
19,837 |
|
- |
|
Bosko Gianna M |
SVP, CAO, GC and secretary |
|
2011-01-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
250 |
11,418 |
|
- |
|
Barrett Ronald W |
Chief Executive Officer |
|
2011-01-31 |
4 |
D |
$7.88 |
$3,609 |
D/D |
(458) |
38,146 |
|
- |
|
Barrett Ronald W |
Chief Executive Officer |
|
2011-01-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,250 |
38,604 |
|
- |
|
Harris William G |
SVP, Finance and CFO |
|
2011-01-28 |
4 |
D |
$7.80 |
$3,276 |
D/D |
(420) |
37,480 |
|
- |
|
Harris William G |
SVP, Finance and CFO |
|
2011-01-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,000 |
37,900 |
|
- |
|
663 Records found
|
|
Page 11 of 27 |
|
|